Recommendation for Non-Palpable Scrotal Mass
Perform scrotal ultrasound (with or without Doppler) as the initial and primary imaging modality for any non-palpable scrotal mass, regardless of how it was discovered. 1
Initial Diagnostic Approach
Ultrasound is nearly 100% sensitive for detecting intrascrotal masses and 98-100% accurate for distinguishing intratesticular from extratesticular lesions 1. The ACR Appropriateness Criteria (2022) explicitly designate US scrotum or US duplex Doppler scrotum as "usually appropriate" for initial imaging of scrotal abnormalities, whether palpable or not 1.
Key Imaging Characteristics to Document:
- Location: Intratesticular versus extratesticular (critical distinction)
- Size: Measure maximum diameter in millimeters
- Echogenicity: Hypoechoic, hyperechoic, or heterogeneous pattern
- Vascularity: Doppler flow characteristics
- Margins: Well-defined versus irregular
Management Algorithm Based on Ultrasound Findings
For Lesions <10mm with Negative Tumor Markers:
Surveillance is a reasonable option based on recent evidence 2. The 2025 study demonstrates that growth parameters can effectively differentiate malignant from benign lesions:
- Follow-up schedule: Serial ultrasounds every 3 months initially
- Concerning growth patterns suggesting malignancy:
- Maximum diameter increase >1mm in 3 months
- Maximum diameter increase >2mm in 6 months
- Velocity of diameter increase >10 × 10⁻³ mm/day 2
Critical caveat: Of 130 small incidentalomas followed, 18/28 growing lesions proved malignant 2. However, 88 remained stable and 14 decreased or disappeared, supporting surveillance as safe when properly monitored.
For Any Solid Intratesticular Mass:
Proceed to surgical exploration via inguinal approach because:
- US cannot definitively differentiate benign from malignant testicular lesions 1
- All hypoechoic or inhomogeneous intratesticular lesions are considered suspicious 1
- Malignancy rates in non-palpable masses range from 50-89% in surgical series 3, 4
Surgical Management Considerations
Testis-sparing surgery with intraoperative frozen section may be considered for:
- Lesions <10mm
- Negative tumor markers (AFP, β-hCG, LDH)
- Patient preference for organ preservation 5
Important limitation: Frozen section analysis showed inconsistent results in 4/9 patients (44%) in one series, with final pathology differing from frozen diagnosis 4. This unreliability means radical orchiectomy should be performed if frozen section suggests malignancy or is indeterminate.
What NOT to Do
- Do not obtain MRI as initial imaging - it is not routinely appropriate and adds no proven benefit over ultrasound for initial evaluation 1
- Do not obtain CT scan - no role in initial workup 1
- Do not obtain nuclear medicine scan - no supporting literature 1
- Do not rely solely on frozen section to preserve the testis if there is any diagnostic uncertainty 4
Tumor Marker Assessment
Always obtain serum tumor markers (AFP, β-hCG, LDH) before any intervention:
- Negative markers support surveillance for small lesions
- Elevated markers mandate surgical exploration regardless of size
- Markers guide postoperative management and surveillance
Common Pitfalls
- Assuming non-palpable means benign: 50-89% of non-palpable testicular masses prove malignant at surgery 3, 4
- Over-relying on imaging characteristics: Even homogeneous hypoechoic patterns can represent seminoma or other malignancies 1
- Delaying surgery for growing lesions: Any documented growth in a solid intratesticular mass warrants prompt surgical exploration 2
- Trusting frozen section absolutely: Up to 44% discordance rate with final pathology has been reported 4